Top Abstract Purchase Related
Home
>
Node
>
Subnode

Cytogenetics and occupational exposure to solvents: a pilot study on leukemias and myelodysplastic disorders

Vineis, P.; Avanzi, G.C.; Giovinazzo, B.; Ponzio, G.; Cambrin, G.R.; Ciccone, G.

Tumori 76(4): 350-352

1990

ISSN/ISBN: 0300-8916
PMID: 2399564
Document Number: 349178
In a pilot study, 57 patients affected by leukemias or myelodysplastic syndromes were interviewed to identify potential exposure to organic solvents. Cytogenetic analyses were performed in 40 of the 57 patients. Unlike previous investigations, no association was found between the occurrence of chromosomal abnormalities and exposure to organic solvents. An original finding was a strong association between solvent exposure and myelodysplastic disorders (4 certainly exposed and 1 possibly exposed out of 11 patients). Such an observation warrants confirmation from case-control studies.

Document emailed within 1 workday
Secure & encrypted payments

Jensen, P.B.; Nielsen, P.; Nielsen, N.O.; Olivarius, B.D.; Hansen, J.H. 1984: Chronic toxic encephalopathy following occupational exposure to organic solvents. the course after cessation of exposure illustrated by a neurophysiological follow-up study Ugeskrift for Laeger 146(18): 1387-1390
Kristensen, P.; Tvedt, B.; Levy, F. 1989: Late sequelae after occupational exposure to organic solvents. Exposure assessment in diagnosing chronic toxic encephalopathy Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(19-21): 2012-2016
Nisse, C.; Lorthois, C.; Dorp, V.; Eloy, E.; Haguenoer, J.M.; Fenaux, P. 1995: Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study Leukemia 9(4): 693-699
Prieto, F.; Carbonell, F.; Badía, L.; Castel, V.; Pérez Sirvent, M.L. 1985: Cytogenetics in the study of myelodysplastic syndromes Sangre 30(4-C): 669-679
Alessio, L.; Apostoli, P.; Crippa, M. 1994: Multiple occupational exposure to solvents Giornale Italiano di Medicina del Lavoro 16(1-6): 37-42
Seaton, A.; Jellinek, E.H.; Kennedy, P. 1992: Major neurological disease and occupational exposure to organic solvents Quarterly Journal of Medicine 84(305): 707-712
Monaenkova, A.M.; Gladkova, E.V.; Radionova, G.K. 1979: Cardiovascular disorders in exposure to occupational factors and the approaches to their study Gigiena Truda i Professional'nye Zabolevaniya (4): 23-27
Kettaneh, A.; Al Moufti, O.; Tiev, K.P.; Chayet, C.; Tolédano, C.éc.; Fabre, B.én.éd.; Fardet, L.; Cabane, J. 2007: Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies Journal of Rheumatology 34(1): 97-103
Moszczyński, P.; Starek, A.; Słowiński, S. 1978: Activity of non-specific phosphatases and the glycogen content of neutrophils in subjects with occupational exposure to organic solvents of paints and varnishes Wiadomosci Lekarskie 31(18): 1277-1281
Cottica, D.; Grignani, E.; Berri, A. 2012: Exposure to leather dusts and organic solvents--results of the PPTP-shoe study Giornale italiano di medicina del lavoro ed ergonomia 34(1): 43-45
Indulski, J.; Kowalski, Z.; Barański, B.; Jakubowski, M.; Głuszcz, M. 1990: The relationship between exposure monitoring and health status in the occupational setting. An information system on exposure levels and occupational diseases Polish Journal of Occupational Medicine 3(1): 1-13
Frappier-Davignon, L.; St-Pierre, J. 1973: Combined effect of air pollution, occupational exposure, and tobacco habits in obstructive lung diseases. II. Food processing firm: no occupational exposure L'Union Medicale du Canada 102(7): 1542-1546
Ueda, T.; Tohyama, K.; Wano, Y.; Tsutani, H.; Fukushima, T.; Iwasaki, H.; Urasaki, Y.; Gotoh, N.; Kimura, S.; Okumura, E. 1994: Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome Anticancer Research 14(5b): 2093-2097
Posokhin, V.V. 2004: Combined neurologic disorders under exposure to occupational hazards Meditsina Truda i Promyshlennaia Ekologiia 12: 36-38
Legrand, O.; Zompi, S.; Perrot, J-Yves.; Faussat, A-Marie.; Benderra, Z.; Chaoui, D.; Marie, J-Pierre. 2004: P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups Haematologica 89(1): 34-41
Lessard, M.; Gervais, C.; Struski, S. 2003: Chromosomal abnormalities in secondary myelodysplastic syndromes and leukemias Pathologie-Biologie 51(6): 356-365
Nakai, H.; Kaneko, H.; Nakao, M.; Horiike, S.; Misawa, S. 1994: Is inactivation of the p53 gene a common event in leukemias and myelodysplastic syndrome with monosomy 17p? Leukemia 8(7): 1247-1248
Gnelitskiĭ, G.I.; Karacharova, S.V.; Gerasimova, M.M. 1989: Pathogenetic connections between psycho-organic disorders in occupational diseases induced by exposure to antibiotics Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 89(12): 78-82
Bernell, P.; Kimby, E.; Hast, R. 1994: Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in acute myeloid leukemia evolving from myelodysplastic syndromes: a pilot study Leukemia 8(10): 1631-1639
Wechsler, L.S.; Checkoway, H.; Franklin, G.M.; Costa, L.G. 1991: A pilot study of occupational and environmental risk factors for Parkinson's disease Neurotoxicology 12(3): 387-392